Radioimmunotherapy of Infectious Diseases

Seminars in Nuclear Medicine

Volumn 39, Issue 2, 2009, Pages 146-153

  Dadachova, Ekaterina ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH 213; INDIUM 111; IODINE 124; IODINE 131; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 18B7 BI 213; MONOCLONAL ANTIBODY 18B7 RE 188; MONOCLONAL ANTIBODY 246D RE 188; MONOCLONAL ANTIBODY 9C7 RE 188; RHENIUM 188; TECHNETIUM 99M; UNCLASSIFIED DRUG; YTTRIUM 90;

APOPTOSIS; BACILLUS ANTHRACIS; BACTERIAL INFECTION; CRYPTOCOCCUS NEOFORMANS; DOSE RESPONSE; DRUG MECHANISM; HISTOPLASMA CAPSULATUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOSIS; NONHUMAN; RADIOIMMUNOTHERAPY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STREPTOCOCCUS PNEUMONIAE; VIRUS INFECTION;

EID: 58849115567     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2008.10.007     Document Type: Review

References (36)

1. Casadevall A., Dadachova E., and Pirofski L. Passive antibody therapy for infectious diseases. Nat Rev Microbiol 2 (2004) 695-703
2. Dadachova E., Nakouzi A., Bryan R., et al. Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection. Proc Natl Acad Sci U S A 100 (2003) 10942-10947
3. Dadachova E., Howell R.W., Bryan R.A., et al. Susceptibility of human pathogens Cryptococcus neoformans and Histoplasma capsulatum to gamma radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes. J Nucl Med 45 (2004) 313-320
4. Martinez L.R., Bryan R.A., Apostolidis C., et al. Antibody-guided alpha-radiation effectively damages fungal biofilms. Antimicrob Agents Chemother 50 (2006) 2132-2136
5. Dadachova E., Burns T., Bryan R.A., et al. Feasibility of radioimmunotherapy of experimental pneumococcal infection. Antimicrob Agents Chemother 48 (2004) 1624-1629
6. Dadachova E., Patel M.C., Toussi S., et al. Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins. PLoS Med 3 (2006) e427
7. Dadachova E., and Casadevall A. Antibodies as delivery vehicles for radioimmunotherapy of infectious diseases. Expert Opinion Drug Deliv 2 (2005) 1075-1084
8. van Eerd J.E., Oyen W.J., Harris T.D., et al. Scintigraphic imaging of infectious foci with an 111In-LTB4 antagonist is based on in vivo labeling of granulocytes. J Nucl Med 46 (2005) 786-793
9. van Eerd J.E., Rennen H.J., Oyen W.J., et al. Scintigraphic detection of pulmonary aspergillosis in rabbits with a radiolabeled leukotriene b4 antagonist. J Nucl Med 45 (2004) 1747-1753
10. Rusckowski M., Gupta S., Liu G., et al. Investigations of a 99mTc-labeled bacteriophage as a potential infection-specific imaging agent. J Nucl Med 45 (2004) 1201-1208
11. Siaens R., Eijsink V.G., Dierckx R., et al. 123I-Labeled chitinase as specific radioligand for in vivo detection of fungal infections in mice. J Nucl Med 45 (2004) 1209-1216
12. Lupetti A., Welling M.M., Mazzi U., et al. Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections. Eur J Nucl Med Mol Imaging 29 (2002) 674-679
13. Lupetti A., Welling M.M., Pauwels E.K., et al. Detection of fungal infections using radiolabeled antifungal agents. Curr Drug Targets 6 (2005) 945-954
14. Line B.R., Breyer R.J., McElvany K.D., et al. Evaluation of human anti-mouse antibody response in normal volunteers following repeated injections of fanolesomab (NeutroSpec), a murine anti-CD15 IgM monoclonal antibody for imaging infection. Nucl Med Commun 25 (2004) 807-811
15. Love C., Tronco G.G., and Palestro C.J. Imaging of infection and inflammation with 99mTc-Fanolesomab. Q J Nucl Med Mol Imaging 50 (2006) 113-120
16. Spitzer E.D., Spitzer S.G., Freundlich L.F., et al. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 341 (1993) 595-596
17. Currie B.P., and Casadevall A. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin Infect Dis 19 (1994) 1029-1033
18. Larsen R.A., Pappas P.G., Perfect J., et al. Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis. Antimicrob Agents Chemother 49 (2005) 952-958
19. Retallack D.M., and Woods J.P. Molecular epidemiology, pathogenesis, and genetics of the dimorphic fungus Histoplasma capsulatum. Microbes Infect 1 (1999) 817-825
20. Nosanchuk J.D., Steenbergen J.N., Shi L., et al. Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Invest 112 (2003) 1164-1175
21. Little S.J., Holte S., Routy J.P., et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 347 (2002) 385-394
22. Ho D.D., Moudgil T., and Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 321 (1989) 1621-1625
23. Casadevall A., Goldstein H., and Dadachova E. Targeting viruses-harboring host cells with radiolabeled antibodies. Expert Opinion Biol Ther 7 (2007) 595-597
24. Dadachova E., Bryan R.A., Frenkel A., et al. Evaluation of acute hematological and long-term pulmonary toxicity of radioimmunotherapy of Cryptococcus neoformans infection in murine models. Antimicrob Agents Chemother 48 (2004) 1004-1006
25. Behr T.M., Behe M., Stabin M.G., et al. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: Therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model. Cancer Res 59 (1999) 2635-2643
26. Sharkey R.M., Blumenthal R.D., Behr T.M., et al. Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma. Int J Cancer 72 (1997) 477-485
27. Koenig T.R., Munden R.F., Erasmus J.J., et al. Radiation injury of the lung after three-dimensional conformal radiation therapy. AJR Am J Roentgenol 178 (2002) 1383-1388
28. Milenic D., Garmestani K., Dadachova E., et al. Radioimmunotherapy of human colon carcinoma xenografts using a (213)Bi-labeled domain-deleted humanized monoclonal antibody. Cancer Biother Radiopharm 19 (2004) 135-147
29. Macklis R.M. How and why does radioimmunotherapy works?. Int J Radiat Oncol Biol Phys 59 (2004) 1269-1271
30. Bryan R.A., Huang X., Morgenstern A., et al. Radio-fungicidal effects of external gamma radiation and antibody-targeted beta and alpha radiation on Cryptococcus neoformans. Antimicrob Agents Chemother 52 (2008) 2232-2235
31. Deere D., Shen J., Vesey G., et al. Flow cytometry and cell sorting for yeast viability assessment and cell selection. Yeast 14 (1998) 147-160
32. Benincasa M., Scocchi M., Pacor S., et al. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J Antimicrob Chemother 58 (2006) 950-959
33. Bryan R.A., Zaragoza O., Zhang T., et al. Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans. Eukaryot Cell 4 (2005) 465-475
34. Madeo F., Herker E., Wissing S., et al. Apoptosis in yeast. Curr Opin Microbiol 7 (2004) 655-660
35. Dadachova E., Bryan R.A., Apostolidis C., et al. Interaction of radiolabeled antibodies with fungal cells and components of immune system in vitro and during radioimmunotherapy of experimental fungal infection. J Infect Dis 193 (2006) 1427-1436
36. Dadachova E., Nosanchuk J.D., Shi L., et al. Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a monoclonal antibody to melanin. Proc Natl Acad Sci U S A 101 (2004) 14865-14870